Physician

Avinash Nari Ramchandani, MD

According to 2025 Medicare claims, Avinash Ramchandani, MD (NPI: 1730358532) practices pain management in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is PROVIDENCE MEDICAL FOUNDATION (NPI: 1740584473; TIN: 330185031) and primary practice location at 95405-4558. Ramchandani is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), participating under the MSSP model.

Ramchandani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 641 traditional Medicare patients, billed 13,012 HCPCS/CPT codes, and received $447,050 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,520 prescription claims across 226 beneficiaries totaling $126,215 in drug costs, led by Movantik (Naloxegol Oxalate). 2020 DME data shows 14 claims. Open Payments data shows 17 records totaling $836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $277,556 and ending at $447,050. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $50,420 to $126,215. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $31,889 to $14,622.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$314K$629K2015 Medicare payment: $277,556 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $467,444 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $323,542 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $473,608 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $628,596 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $535,006 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $461,082 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $339,233 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $445,720 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $447,050 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156444,166$277,556
20168207,637$467,444
20176264,535$323,542
20184405,667$473,608
20194076,827$628,596
20204585,690$535,006
20214864,464$461,082
20224846,574$339,233
202357114,873$445,720
202464113,012$447,050

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$121K$242K2015 Drug cost: $50,420 (USD; Tot_Drug_Cst)2016 Drug cost: $82,649 (USD; Tot_Drug_Cst)2017 Drug cost: $67,046 (USD; Tot_Drug_Cst)2018 Drug cost: $99,389 (USD; Tot_Drug_Cst)2019 Drug cost: $215,477 (USD; Tot_Drug_Cst)2020 Drug cost: $182,712 (USD; Tot_Drug_Cst)2021 Drug cost: $178,609 (USD; Tot_Drug_Cst)2022 Drug cost: $242,267 (USD; Tot_Drug_Cst)2023 Drug cost: $150,912 (USD; Tot_Drug_Cst)2024 Drug cost: $126,215 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153201,063$50,420
20163621,651$82,649
20172891,243$67,046
20182051,387$99,389
20192542,650$215,477
20203662,648$182,712
20214842,525$178,609
20223172,706$242,267
20232491,444$150,912
20242261,520$126,215

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$18K$37K2015 Medicare payment: $23,819 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $36,600 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $15,789 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $725 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $92 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $490 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015147480$23,819
20162811,203$36,600
2017155774$15,789
20181264$725
20192323$92
2020N/R14$490
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more109109$135
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3371,174$101
99442Telephone medical discussion with physician, 11-20 minutes350791$74
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's218509$13
J1100Injection, dexamethasone sodium phosphate, 1 mg781,174$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MovantikNaloxegol Oxalate21870$11,505
BuprenorphineBuprenorphine441,104$9,805
Ajovy SyringeFremanezumab-Vfrm13390$8,919
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl28818$7,000
Oxycodone HclOxycodone Hcl1503,453$3,819

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$836Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Avinash Nari Ramchandani, MD?

Tedicare shows public-source Medicare data for Avinash Nari Ramchandani, MD (NPI 1730358532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Avinash Nari Ramchandani, MD have ACO affiliation data?

Avinash Nari Ramchandani, MD is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342).

What billing organization is linked to Avinash Nari Ramchandani, MD?

Avinash Nari Ramchandani, MD is linked to PROVIDENCE MEDICAL FOUNDATION (billing NPI 1740584473) in the available physician profile data.

Does Avinash Nari Ramchandani, MD have Open Payments data?

Avinash Nari Ramchandani, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.